Skip to main content

Pfizer Extends License to Gene Logic s ToxExpress Database

NEW YORK, Oct. 4 - Gene Logic of Gaithersburg, Md., said Thursday that Pfizer had extended it subscription to Gene Logic's ToxExpress database module. 

Pfizer, which has had access to ToxExpress since 2000, extended its total subscription term to five years. 

Gene Logic did not disclose financial terms of the deal. 

In January, Gene logic and Pfizer announced an agreement to jointly develop a microarray for toxicology studies using Affymetrix’s GeneChip technology.

Under the agreement, Gene Logic and Pfizer researchers said they would design the array, while Affymetrix would build it. The array will only be available to subscribers of Gene Logic’s ToxExpress and is designed to complement the ToxExpress’s library of toxicity markers.   

ToxExpress is a module in the GeneExpress suite of databases. It offers data on the effects of more than 10 toxic compounds on the liver, kidney, bone marrow, and heart of animals.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.